Related by context. All words. (Click for frequent words.) 61 serologic testing 60 postdischarge 60 virological response 60 treat NNT 59 posttransplant 59 nonvertebral fracture 59 antimicrobial prophylaxis 59 cranial irradiation 58 seropositivity 58 neurologic sequelae 58 medication nonadherence 58 hepatic resection 58 anagrelide 58 NIHSS score 58 adjuvant tamoxifen 58 lymphocyte count 58 perioperative mortality 58 HbA 1c levels 58 SLNB 58 postexposure prophylaxis 58 oral anticoagulation 57 posttreatment 57 nonvertebral fractures 57 adenoma recurrence 57 multivariable adjusted 57 pulmonary resection 57 Kaplan Meier curves 57 Retreatment 57 histological subtype 57 antibiotic regimens 57 pharmacologic intervention 57 NNT = 57 ICD therapy 57 vaccinees 57 Postoperative complications 57 % CI #.#-#.# [003] 57 fragility fracture 57 CR nPR 57 androgen suppression 57 symptomatic VTE 57 CORE OM 57 R0 resection 57 chest radiographs 57 de aths 57 adverse cytogenetics 56 advanced neoplasia 56 PSADT 56 logistic regression model 56 COPD exacerbations 56 guideline concordant 56 peripartum 56 virologic failure 56 anemia hemoglobin 56 renal biopsy 56 biochemical relapse 56 % CI #.#-#.# [008] 56 liver transplant recipients 56 postoperative complication 56 LDB CPR 56 varicella infection 56 VTE prophylaxis 56 abnormal Pap smears 56 timepoints 56 venous thromboembolic disease 56 IPAH 56 COPD exacerbation 56 HSCT 56 preoperative PSA 56 ofpatients 56 MMSE score 56 Heavy menstrual bleeding 56 fetal malformations 56 spontaneous preterm birth 56 % CI #.#-#.# [007] 56 Evaluable 56 neurodevelopmental impairment 56 PSA nadir 56 antithrombotic therapy 56 ICD implants 56 postexposure 56 postoperative mortality 55 genotypic resistance 55 elevated LDH 55 extracolonic findings 55 postvaccination 55 reperfusion therapy 55 inhospital 55 antibody titer 55 moderately emetogenic 55 polyp recurrence 55 renal cysts 55 postoperative morbidity 55 ALT flares 55 recurrent venous thromboembolism 55 Pneumococcal vaccination 55 hepatitis C genotype 55 multivariable analyzes 55 β blockers 55 concomitant antibiotics 55 antibiotic prophylaxis 55 hepatectomy 55 parathyroidectomy 55 evaluable subjects 55 thiopurine 55 multivariable analysis 55 biochemical recurrence 55 chronic hemodialysis 55 #OHD 55 susceptible isolates 55 thromboprophylaxis 55 glucocorticoid therapy 55 clinically meaningful improvement 55 sacral neuromodulation 55 postoperative radiotherapy 55 EDSS score 55 pneumococcal vaccination 55 invasive aspergillosis 55 adjuvant therapies 55 hepatorenal syndrome 55 HIV seroconversion 55 postintervention 55 undergoing bariatric surgery 55 doxorubicin docetaxel 55 curative therapy 55 Y BOCS 55 acromegalic patients 55 Kaplan Meier analysis 55 angiographically 55 univariate analyzes 55 malignant neoplasm 55 retransplantation 55 CDI recurrence 55 neurocognitive deficits 55 hematologic abnormalities 55 neurologic complications 55 Hb A1C 55 palivizumab 55 adnexal mass 55 underwent resection 55 serum aminotransferase levels 55 p = .# [002] 55 subtrochanteric 54 ICD implantation 54 mycophenolate mofetil MMF 54 preterm deliveries 54 Medullary thyroid cancer 54 pacemaker implantation 54 methotrexate monotherapy 54 conjugated equine estrogen 54 rebleeding 54 Aspergillus infections 54 lupus anticoagulant 54 colorectal adenoma 54 CRBSI 54 warfarin dosage 54 femoral neck fracture 54 NIH CPSI 54 inhospital mortality 54 Viral load 54 chronic GVHD 54 suboptimal adherence 54 ICD shocks 54 reoperations 54 coinfection 54 HRQL 54 alteplase 54 nonsevere 54 timepoint 54 intravenous thrombolysis 54 candidemia 54 pharmacologic treatments 54 psychiatric comorbidity 54 HPA axis suppression 54 log# reduction 54 definite stent thrombosis 54 recurrent ischemic stroke 54 logistic regression models 54 abnormal Pap smear 54 pelvic lymphadenectomy 54 complete cytogenetic response 54 divalproex sodium 54 undetectable HBV DNA 54 noncancer 54 PASI scores 54 carotid stenosis 54 nonpregnant women 54 cytoreduction 54 extubation 54 postoperative infection 54 postoperative pulmonary 54 inotropic 54 initiating HAART 54 stratifying patients 54 Bonferroni correction 54 liver transplantations 54 rFVIIa 54 variceal bleeding 54 underwent liver transplantation 54 Cognitive impairment 54 invasive fungal infection 54 FiO 54 pretest probability 54 nonadherence 54 postoperative infections 54 perioperative complications 53 corticosteroid dose 53 seroconversion 53 causative pathogen 53 hyperacute 53 underdiagnosis 53 Influenza vaccination 53 perioperatively 53 NNRTI resistance 53 pyridostigmine 53 ruptured aneurysms 53 pretreatment serum 53 cART 53 univariate analysis 53 Renal dysfunction 53 TMP SMX 53 allogeneic transplant 53 upper gastrointestinal bleeding 53 atherogenic dyslipidemia 53 ECD kidneys 53 Arch Intern Med 53 nephrolithiasis 53 HBV infections 53 anti HBs 53 epoetin alpha 53 comorbid conditions 53 plasma cortisol 53 multivariate regression analysis 53 tuberculin skin testing 53 pretransplant 53 oncologic outcomes 53 thrombotic complications 53 IOP lowering 53 monoclonal gammopathy 53 morbidity mortality 53 adjuvant cisplatin 53 thrombolytic therapy 53 interquartile range 53 CVD mortality 53 warfarin therapy 53 lymphocyte counts 53 virological failure 53 intrapartum 53 % Confidence Interval 53 periprocedural 53 androgen ablation 53 intracranial hemorrhage ICH 53 morphometric vertebral fractures 53 enterococcal 53 TKAs 53 mammographic density 53 reintubation 53 randomized controlled trials RCTs 53 conventional angiography 53 neonatal morbidity 53 comorbid diagnoses 53 hemodialysis patients 53 anastomotic leak 53 carotid IMT 53 serum cortisol 53 perioperative morbidity 53 visceral metastases 53 confidence interval #.#-#.# 53 dose Iluvien 53 HCV antibody 53 CYP#D# inhibitor 53 TURBT 53 recurrent VTE 53 NIHSS 53 microscopic hematuria 53 colectomy 53 unplanned readmissions 53 gonococcal infection 53 virologic suppression 53 resynchronization therapy 53 C. trachomatis 53 interstitial brachytherapy 53 S. aureus infection 53 dosage regimens 53 virologic responses 53 oral prednisolone 53 poor metabolizers 53 myocardial fibrosis 53 tumor histology 53 periprocedural MI 53 neutropaenia 53 vaginal hysterectomy 53 bronchoalveolar lavage BAL 53 progression TTP 53 #mg dose [002] 53 pulmonary dysfunction 53 subscore 53 prospective multicenter study 53 Thal Dex 53 symptomatic intracranial hemorrhage 53 potent antiretroviral therapy 53 abnormal cytology 53 BSIs 53 ADEs 53 URTI 53 empiric treatment 53 LV dysfunction 53 abnormal Pap test 53 cytologic 53 cytogenic 53 virologic breakthrough 53 adenotonsillectomy 53 endometrial carcinoma 53 MPRs 53 comorbid psychiatric 53 advanced adenoma 53 oral anticoagulant therapy 53 CMV infection 53 HIV HCV coinfected 53 severe asthma exacerbations 53 urine dipstick 52 ipsilateral stroke 52 acute respiratory tract infections 52 adjuvant endocrine therapy 52 IQR 52 tumor regressions 52 asthma exacerbations 52 EuroSCORE 52 salmeterol fluticasone 52 estimated GFR 52 OIs 52 clot busting therapy 52 nonoperative treatment 52 comorbid depression 52 screening colonoscopy 52 Febrile neutropenia 52 ertapenem 52 authors hypothesized 52 meta analytic 52 surgical debulking 52 oocytes retrieved 52 ß blockers 52 comorbid illnesses 52 Readmissions 52 thrombophilia 52 GH deficiency 52 extensive metabolizers 52 nonadherent 52 cerebral oxygen saturation 52 RUGs IV 52 chemoradiation therapy 52 beta blocker therapy 52 bolus dose 52 C. diff infections 52 hematologic parameters 52 gm dL 52 Kaplan Meier estimates 52 Infusion Reactions Severe 52 metaanalysis 52 HIV coinfected 52 antiviral therapy 52 serum PTH 52 relapsed MM 52 intraoperative complications 52 HIV uninfected 52 antenatal corticosteroids 52 tipranavir r 52 immunosuppressive regimens 52 serum HCV RNA 52 Ishak fibrosis score 52 thrombocytopenic 52 mesalamine granules 52 Kaplan Meier 52 aortic root replacement 52 remission CR 52 coronary revascularization 52 myocardial infarctions MIs 52 Symptom Checklist 52 hematological parameters 52 creatinine ratio 52 HbA1C levels 52 Comorbidities 52 androgen deprivation 52 Multivariate analysis revealed 52 abacavir Ziagen 52 parasitemia 52 SCr 52 rFSH 52 antioxidant supplementation 52 Hib vaccination 52 immunosuppression therapy 52 labetalol 52 diagnosing coronary artery 52 antidiabetic medication 52 antiviral regimens 52 adrenalectomy 52 liver histology 52 bacteriuria 52 urodynamic parameters 52 operable breast cancer 52 asthma exacerbation 52 perinatal outcomes 52 mortality morbidity 52 rehospitalization 52 antiplatelet medication 52 ejection fractions 52 pH#N# 52 clinicopathologic 52 unsedated colonoscopy 52 prostate cancer CaP 52 parasitaemia 52 Liver transplantation 52 unruptured aneurysm 52 coagulation abnormalities 52 HBeAg seroconversion 52 adjuvant radiotherapy 52 p = #.# [003] 52 Stent thrombosis 52 lowest tertile 52 graft occlusion 52 T1DM 52 postoperative hemorrhage 52 EBUS FNA 52 Injury Severity Score 52 lumbar spine BMD 52 HBeAg + 52 nadir CD4 cell 52 HRQoL 52 CHADS2 52 WNV infections 52 ECLS 52 undergoing liver transplantation 52 hemorrhagic complications 52 binary restenosis 52 humoral responses 52 perinatal complications 52 histologically proven 52 intact parathyroid hormone 52 symptomatic intracerebral hemorrhage 52 experienced virologic failure 52 HBeAg 52 defibrillator implant 52 EDSS scores 52 MS DRG 52 hysterectomies performed 52 fluticasone salmeterol 52 Calcium intake 52 unicompartmental knee arthroplasty 52 interobserver reliability 52 CIN2 + 52 herpes zoster vaccine 52 chronic prostatitis chronic 52 percutaneous drainage 52 omnicef 52 BRCA2 mutation carriers 52 bladder carcinoma 52 multivariate Cox 52 pCR 52 body habitus 51 postoperative AF 51 QALE 51 arterial thromboembolic events 51 inpatient hospitalizations 51 ECOG PS 51 neurologic impairment 51 intravascular volume 51 acute cholecystitis 51 postsurgical 51 BMI z 51 chemoradiotherapy 51 meta regression 51 PCIs 51 MTWA testing 51 antithrombotic therapies 51 viremia 51 DVT PE 51 Caesarean deliveries 51 pulmonary hypoplasia 51 colonoscopic 51 cerebrovascular accidents 51 preoperative diagnosis 51 hyperbilirubinemia 51 salmeterol fluticasone propionate 51 μg liter 51 STN stimulation 51 GBA mutations 51 noncardiovascular mortality 51 mL/min/#.# m 2 51 confidence intervals CIs 51 serum lipid levels 51 rhGH 51 perinatal transmission 51 micronutrient supplementation 51 cirrhotic patients 51 neurocognitive impairment 51 rt PA 51 sociodemographic factors 51 XIENCE V PROMUS Stent 51 lung resection 51 cardioembolic stroke 51 NATRECOR ® 51 baseline CD4 51 symptom onset 51 receiving VICTRELIS 51 NAbs 51 sonographic diagnosis 51 initiating antiretroviral therapy 51 abnormal mammograms 51 varicella vaccination 51 afib 51 platelet reactivity 51 aminotransferase 51 endometrial thickness 51 Lung transplantation 51 KRAS status 51 hydroxyvitamin D levels 51 neoadjuvant treatment 51 mutated K ras 51 secondary efficacy endpoint 51 HER2 expression 51 cotrimoxazole 51 posttest 51 neutropenic fever 51 knee arthroplasty 51 DHEA supplementation 51 Multivariate analysis 51 transfusion transmitted 51 nucleoside naive patients 51 silent myocardial ischemia 51 CRp 51 latent tuberculosis infection 51 NMIBC 51 ventilation perfusion 51 certolizumab 51 diabetic polyneuropathy 51 atherothrombotic 51 locoregional 51 recurrent ischemia 51 hepatic encephalopathy HE 51 cotrimoxazole prophylaxis 51 coinfected patients 51 preoperative chemotherapy 51 ovulatory 51 tertiles 51 thoracoscopic lobectomy 51 adenoma detection 51 RSV hospitalizations 51 PNH patients 51 hydroxyurea therapy 51 patients undergoing CABG 51 nonfasting triglyceride levels 51 STRIDE PD 51 vivo potency 51 diagnostic laparoscopy 51 severely immunocompromised patients 51 HACs 51 etiologic 51 Target Lesion Revascularization TLR 51 neurodevelopmental outcomes 51 glycated hemoglobin levels 51 KDOQI guidelines 51 pneumococcal infection 51 interferon ribavirin 51 Venous thromboembolism 51 liver metastasis 51 ASCUS 51 mRS 51 dosing cohort 51 RELIANT Trial 51 MADRS score 51 prodromal symptoms 51 regression coefficient 51 urolithiasis 51 detectable HCV RNA 51 pancreatectomy 51 antiandrogens 51 Subgroup analyzes 51 intratympanic 51 % CI #.#-#.# [005] 51 MGUS 51 euthyroid 51 nondiabetic patients 51 bacillus Calmette Guerin 51 baseline HbA1c 51 LAGB 51 sero positive 51 baseline LDH 51 aneurysm rupture 51 revascularization procedure 51 CCyR 51 gastric adenocarcinoma 51 hippocampal atrophy 51 preterm neonates 51 recurrent preterm birth 51 gonococcal infections 51 histologic subtype 51 bivariate analysis 51 hemodynamic variables 51 autonomic dysfunction 51 albumin excretion rate 51 percutaneous vertebroplasty 51 serum sodium levels 51 radiotherapy RT 51 Heritability 51 severe rotavirus gastroenteritis 51 systemic hypotension 51 solifenacin 51 reinfarction 51 unmeasured confounding 51 thalidomide dexamethasone 51 myocardial revascularization 51 ARB telmisartan 51 pulmonary exacerbation 51 lower extremity amputation 51 logistic regression analysis 51 events ADEs 51 homocysteine concentrations 51 nontraumatic 51 TroVax ® 51 pancreatic resection 51 HPV subtypes 51 eculizumab therapy 51 atrophic gastritis 51 carotid plaque 51 vasogenic edema 51 Recurrences 51 CHDs 51 Comorbidity 51 endotracheal intubation 51 Hydroxyurea 51 antiretroviral naïve 51 biologic DMARDs 51 observational cohort study 51 Twinrix 51 decompensation 51 psychiatric comorbidities 51 cinacalcet 51 Adjuvant chemotherapy 51 HeFH 51 Thrombocytopenia 51 logistic regression analyzes 51 HbF 51 pamidronate 51 hemorrhagic cystitis 51 multivariate analyzes 51 serum estradiol 51 EBV infection 50 physiologic responses 50 Ann Intern Med 50 Nonadherence 50 diabetes mellitus DM 50 CIN3 50 plasma pharmacokinetics 50 electrophysiologic 50 nadroparin 50 revascularization procedures 50 PROLARIS 50 APTIVUS r 50 Univariate analysis 50 GnRH antagonist 50 P. falciparum malaria 50 recurrent miscarriage 50 adenomatous polyps 50 subscale scores 50 OAB symptoms 50 adenoidectomy 50 empiric therapy 50 MS DRGs 50 RARP 50 LNG IUS 50 aldosterone antagonist 50 cranial radiation 50 carotid artery stenting CAS 50 malaria endemic regions 50 postoperative complications 50 sensitivity specificity 50 bacteraemia 50 MCyR 50 preintervention 50 antimicrobial susceptibility 50 isoniazid preventive therapy 50 orofacial clefts 50 haematologic 50 chemoprevention trials 50 MitraClip device 50 coronary revascularization procedures 50 â ‰ ¥ 50 spirometric 50 prospective observational cohort 50 mIU ml 50 cells μL 50 RYGB 50 nonobese 50 elevated bilirubin 50 antiviral prophylaxis 50 nonfatal MI 50 postpartum hemorrhage 50 leukocyte count 50 Cesarean deliveries 50 lymph node dissection 50 baseline FEV 50 tapentadol ER 50 cardiac revascularization 50 methacholine challenge 50 pharmacokinetic interaction 50 FDG PET scan 50 pharmacodynamic parameters 50 TPV r 50 antiplatelet therapies 50 K DOQI guidelines 50 disease progression TTP 50 chronic urticaria 50 fluoroquinolone resistance 50 depressive symptomatology 50 chlamydial infection 50 endometrial biopsy 50 Pegylated Interferon 50 bone scintigraphy 50 PRADAXA 50 endometrial hyperplasia 50 HER2 overexpression 50 Antiretroviral therapy 50 neurodevelopmental outcome 50 QALY gained 50 tropism testing 50 genital herpes infections 50 molar pregnancy 50 DSM IV diagnosis 50 peritoneal cancer 50 Operative mortality 50 nonoperative 50 Cimzia TM 50 prostaglandin analogues 50 hemodilution 50 F FDG PET 50 postop 50 interquartile range IQR 50 radiographic progression 50 Score DAS# 50 DLQI 50 hepatic cirrhosis 50 C. difficile colitis 50 angiographic outcomes 50 VT VF 50 postoperative atrial fibrillation 50 dietary carbohydrate 50 prognostic variables 50 AUDs 50 atrioventricular block 50 CSF biomarkers 50 multivariable adjustment 50 inflammatory biomarkers 50 artery stenosis 50 gonococcal 50 de ath 50 PRADAXA #mg 50 hypoglycemic episodes 50 Sociodemographic 50 clinicopathological features 50 EDARBI 50 QIDS SR 50 AMOR IPAT 50 HAQ DI 50 trastuzumab Herceptin ® 50 androgen blockade 50 ribavirin therapy 50 Suboptimal 50 virological suppression 50 Afib 50 polymicrobial 50 Hypotension 50 pentoxifylline 50 P = .# 50 antireflux surgery 50 ICD CRT 50 SUVmax 50 perfusion abnormalities 50 BRCA mutation carriers 50 electrical cardioversion 50 chorioamnionitis 50 noncardiac 50 axillary node dissection 50 antidiabetic medications 50 ximelagatran 50 pathologic fractures 50 HAART regimens 50 macroalbuminuria 50 sCJD 50 thyrotropin levels 50 external genital lesions 50 NICE guideline 50 revaccination 50 co morbidities 50 colorectal liver metastases 50 ALI ARDS 50 radioiodine therapy 50 virus HBV 50 untreated OSA 50 CPT code 50 diagnosed prenatally 50 % CI #.#-#.# [006] 50 codes #-# 50 micronutrient supplements 50 hsCRP levels 50 empyema 50 anticoagulation therapy 50 transaminase levels 50 conditional logistic regression 50 prospectively stratified 50 Antibiotic prophylaxis 50 inhibin 50 cefazolin 50 paracentesis 50 ELBW infants 50 MRSA colonization 50 microsatellite instability 50 acute rheumatic fever 50 amoxicillin clavulanate 50 postprocedure 50 observational cohort 50 coronary artery occlusion 50 Scale EDSS score 50 polytherapy 50 ventilatory 50 allogeneic transplantation 50 MADIT II 50 multiple logistic regression 50 serologic tests 50 ER CHOP 50 lipid lowering medications 50 hip arthroplasty 50 cytomegalovirus infection 50 hepatitis B vaccination 50 seronegative 50 Exacerbations 50 inhaled corticosteroid therapy 50 sUA 50 reflux symptoms 50 ovarian malignancy 50 odds ratios ORs 50 pathologic examination 50 Combination antiretroviral therapy 50 cerebral angiography 50 colorectal screenings 50 severely immunosuppressed 50 recurrent myocardial infarction 50 tracheal intubation 50 chronic HBV 50 serum urate levels 50 Breslow thickness 50 CTEPH 50 lipid lowering therapy 50 elevated IOP 50 Adenomas 50 retrospective cohort 50 bicuspid aortic valves 50 portal vein thrombosis 50 neurocognitive disorder 50 reinterventions 50 triacylglycerol concentrations 50 Pneumococcal pneumonia 50 DHA supplementation 50 symptom exacerbation 50 HepB vaccine 50 paraprotein 50 morbidities 50 lymphadenectomy 50 nonpregnant 50 thromboembolic 50 MoxDuo TM IR 50 radical retropubic prostatectomy 50 virologic failures 50 dietary sodium 50 postnatally 50 hypovitaminosis D 50 liver biopsies 50 LVNC 50 CsA 50 syndromic 50 leiomyomas 50 analgesic medications 50 albumin excretion 50 RVUs 50 HIB vaccine 50 fetal chromosomal 50 myocardial viability 50 statistical significance p 50 FFR measurements 50 FROVA 49 intravenous diuretics 49 CIN3 + 49 peri procedural 49 familial AF 49 CHD mortality 49 multivariate adjustment 49 Preoperatively 49 AST ALT 49 gastrointestinal bleeds 49 TEAEs 49 atypical ductal hyperplasia 49 FGFR2 gene 49 ATACAND 49 Main Outcome Measure 49 A1c levels 49 MDRD 49 CLABSIs 49 anal incontinence 49 RBC transfusions 49 opioid prescriptions 49 nmol L. 49 HbA 1c 49 PLMs 49 serum lactate 49 echocardiographic parameters 49 obstructive coronary artery 49 CHD coronary 49 pre operatively 49 scintigraphic 49 iPTH 49 Kaplan Meier survival 49 Clinically significant 49 obstructive lung 49 mediastinitis 49 abdominal hysterectomy 49 serum homocysteine 49 post operatively 49 hyperoxaluria 49 covariate 49 chemoprophylaxis 49 serum phosphate 49 severe exacerbations 49 flutamide 49 Polypharmacy 49 ibandronate 49 Visual Analogue Scale VAS 49 QTcF 49 monoinfected patients 49 locoregional recurrence 49 viral titers 49 IPTp 49 HDRS 49 membrane rupture 49 HBeAg positive patients 49 elevated triglyceride levels 49 subfertility 49 rheumatologic 49 sotalol 49 response pCR 49 nonvaccine 49 eosinophilic pneumonia 49 febrile illnesses 49 transrectal ultrasound guided 49 NHAMCS 49 renal flares 49 antiarrhythmic medications 49 tumor necrosis 49 axillary dissection 49 NHANES III 49 NovoSeven ® 49 CD# upregulation 49 BENICAR HCT 49 chronic periodontitis 49 chronic rhinosinusitis CRS 49 varices 49 VLBW infants 49 nulliparous women 49 Tranexamic acid 49 neurologic dysfunction 49 antiandrogen 49 revascularizations 49 Pneumonia vaccine 49 Adverse Event 49 HBV DNA levels 49 clinically meaningful improvements 49 EGFR mutation status 49 cardiac perfusion 49 plasma homocysteine 49 serum sodium concentration 49 Q#IR 49 MIs 49 Tysabri infusions 49 spontaneous preterm delivery 49 MDCT scans 49 prolonged QT intervals 49 TPMT 49 pyelonephritis 49 atherothrombotic disease 49 transient elastography 49 neurologic outcomes 49 Impaired glucose tolerance 49 antiangiogenic therapy 49 syndromal 49 MDRD equation 49 attain statistical significance 49 cardiac repolarization 49 FOLFIRINOX 49 transplant ASCT 49 repolarization 49 prenatally diagnosed 49 serum concentrations